China Pharma Holding Financials - Benzinga

China Pharma Holding Inc

CPHIAMEX

Trade with Public

Trade with Public

$0.7400

0.02012.79%

Ult. Agg.: Sep 24, 1:10 PM

Panoramica Notizie Previsioni utiliDati finanziariSentiment Confronta Rapporto azionario

China Pharma Holding Financials

China Pharma Holding (CPHI) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

PRO
China Pharma Holding Q1 EPS $(0.04) Up From $(0.24) YoY, Sales $983.536K Down From $1.136M YoY

China Pharma Holding (AMEX:CPHI) reported quarterly losses of $(0.04) per share. This is a 83.33 percent increase over losses of $(0.24) per share from the same period last year. The company reported $983.536 thousand

Benzinga Newsdesk

PRO
China Pharma Holding Q4 EPS $(0.17) Up From $(0.40) YoY, Sales $1.226M Up From $1.134M YoY

China Pharma Holding (AMEX:CPHI) reported quarterly losses of $(0.17) per share. This is a 57.5 percent increase over losses of $(0.40) per share from the same period last year. The company reported $1.226 million in

Benzinga Newsdesk

US Stock Futures Drop Following Massive Tariff-Induced Selloff: Experts Warn Of A Brewing 'Great Depression-Like' Pattern

U.S. stock futures fell sharply on Monday after 2-days of the crash before closing last week. Futures were over 3% lower in premarket trading.

Rishabh Mishra

Levi Strauss, Dave & Buster's Entertainment And 3 Stocks To Watch Heading Into Monday

Avi Kapoor

Nasdaq Surges Over 100 Points; US Economy Expands Faster Than Expected

U.S. stocks traded higher this morning, with the Nasdaq Composite gaining more than 100 points on Wednesday. Following the market opening Wednesday, the Dow traded up 0.13% to 35,461.86 while the NASDAQ rose 0.88% to 14,406.93. The S&P 500 also rose, gaining, 0.57% to 4,580.99.

Lisa Levin

PRO
China Pharma Holding On Friday Reported Q1 EPS $(0.06) Up From $(0.20) YoY, Sales $1.96M Up From $1.60M YoY

China Pharma Holding (AMEX:CPHI) reported quarterly losses of $(0.06) per share. This is a 70 percent increase over losses of $(0.20) per share from the same period last year. The company reported $1.96 million in sales

Benzinga Newsdesk

© 2026 Benzinga | All Rights Reserved